Trial
NCT04641273
A 2-part Trial to Learn More About How BAY1817080 Works, How Safe it is, and What the Right Dose is for Participants With Diabetic Neuropathic Pain
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Bayer
Collaborators
—
Condition
Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Intervention
BAY1817080
Why stopped
Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-12-12